Menu
Search
|

Menu

Close
X

Merck KGaA MRCG.DE (Xetra)

92.68 EUR
-- (--)
As of Jul 17
Previous Close 92.68
Open --
Volume --
3m Avg Volume 524,147
Today’s High --
Today’s Low --
52 Week High 102.90
52 Week Low 84.40
Shares Outstanding (mil) 129.24
Market Capitalization (mil) 11,975.59
Forward P/E 43.04
Dividend (Yield %) 1.25 ( 1.35 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.54 Mean rating from 24 analysts

KEY STATS

Revenue (mm, EUR)
FY19
3,746
FY18
14,836
FY17
14,517
FY16
15,024
EPS (EUR)
FY19
0.453
FY18
2.459
FY17
5.863
FY16
3.748
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
43.04
34.16
Price to Sales (TTM)
vs sector
0.79
8.16
Price to Book (MRQ)
vs sector
2.34
4.38
Price to Cash Flow (TTM)
vs sector
4.48
24.12
Total Debt to Equity (MRQ)
vs sector
53.80
18.17
LT Debt to Equity (MRQ)
vs sector
28.61
13.01
Return on Investment (TTM)
vs sector
3.54
12.64
Return on Equity (TTM)
vs sector
6.07
17.19

EXECUTIVE LEADERSHIP

Stefan Oschmann
Chairman of Executive Board and Chief Executive Officer, Since 2016
Salary: €1,300,000.00
Bonus: €3,700,000.00
Wolfgang Buechele
Independent Chairman of the Supervisory Board, Since 2014
Salary: €94,000.00
Bonus: --
Michael Fletterich
Independent Vice Chairman of the Supervisory Board, Employee Representative, Since 2014
Salary: €70,500.00
Bonus: --
Marcus Kuhnert
Member of the Executive Board, Chief Financial Officer, Since 2014
Salary: €900,000.00
Bonus: €2,200,000.00
Udit Batra
Chief Executive Officer Life Science, Member of the Executive Board, Since 2016
Salary: €1,000,000.00
Bonus: €2,800,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Frankfurter Str. 250
DARMSTADT     64293

Phone: +496151.720

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

SPONSORED STORIES